Clinical Trials at AngioCor Blumenau
During the past decade, AngioCor Blumenau conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "AngioCor Blumenau"
#1 collaborator was "University Health Network, Toronto" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at AngioCor Blumenau
According to Clinical.Site data, the most researched conditions in "AngioCor Blumenau" are
"COVID-19" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Pneumonia" (1 trials). Many other conditions were trialed in "AngioCor Blumenau" in a lesser frequency.
Clinical Trials Intervention Types at AngioCor Blumenau
Most popular intervention types in "AngioCor Blumenau" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Evolocumab" (1 trials), "Heparin" (1 trials), "Liquid Alpha1-Proteinase Inhibitor (Human)" (1 trials) and "Lp(a) Screening" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AngioCor Blumenau
The vast majority of trials in "AngioCor Blumenau" are
4 trials for "All" genders.
Clinical Trials Status at AngioCor Blumenau
Currently, there are NaN active trials in "AngioCor Blumenau".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in AngioCor Blumenau,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in AngioCor Blumenau, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".